Poseida Therapeutics News

William Blair Maintains Poseida Therapeutics(PSTX.US) With Buy Rating

Moomoo NewsOct 17 10:31 ET

Poseida Therapeutics Analyst Ratings

BenzingaOct 17 07:13 ET

H.C. Wainwright Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsOct 17 06:31 ET

Piper Sandler Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 30 07:31 ET

BTIG Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsSep 30 06:33 ET

William Blair Maintains Poseida Therapeutics(PSTX.US) With Buy Rating

Moomoo NewsSep 30 06:33 ET

Buy Rating Justified by Poseida Therapeutics' Promising Clinical Trial Results for P-BCMA-ALLO1 in Multiple Myeloma

TipRanksSep 30 05:40 ET

William Blair Maintains Poseida Therapeutics(PSTX.US) With Buy Rating

Moomoo NewsSep 5 05:33 ET

William Blair Maintains Poseida Therapeutics(PSTX.US) With Buy Rating

Moomoo NewsAug 13 05:33 ET

Buy Rating for Poseida Therapeutics: Strategic Partnerships and Innovative Cell Therapy Platform

TipRanksAug 13 04:51 ET

Piper Sandler Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsAug 6 07:40 ET

Poseida Therapeutics Analyst Ratings

BenzingaAug 6 06:54 ET

H.C. Wainwright Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsAug 6 06:33 ET

William Blair Maintains Poseida Therapeutics(PSTX.US) With Buy Rating

Moomoo NewsAug 6 04:31 ET

Buy Rating Affirmed for Poseida Therapeutics Amid Strategic Partnerships and Promising Clinical Developments

TipRanksAug 6 04:20 ET

Poseida Therapeutics Analyst Ratings

BenzingaJul 25 08:28 ET

Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX) and SAGE Therapeutics (SAGE)

TipRanksJul 25 06:42 ET

H.C. Wainwright Maintains Poseida Therapeutics(PSTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsJul 25 06:31 ET

Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX), Greenwich LifeSciences (GLSI) and ACELYRIN, INC. (SLRN)

TipRanksMay 22 06:25 ET

Poseida Therapeutics Analyst Ratings

BenzingaMay 22 06:11 ET